U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748910) titled 'Enhancing Resilience and Quality of Life in Bipolar Disorder Through Cognitive Behavioral Therapy' on July 23.
Brief Summary: Bipolar disorder (BD) is a chronic and recurrent mood disorder characterized by alternating episodes of mania, depression, or mixed states, interspersed with periods of remission. These episodes can severely impair interpersonal relationships, occupational functioning, and overall quality of life. In 2019, approximately 40 million people worldwide were diagnosed with BD.
BD is a lifelong chronic condition despite pharmacotherapy and lifestyle changes. Traditional psychiatric care has primarily focused on symp...